Charles Anthony Laranjeira
CIK 1524338 · View on SEC EDGAR ↗
First SEC filing: June 15, 2018 · Latest: June 15, 2018
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 8, 2022 | PCRX | S 10b5-1 | 267 | $61.98 | $16,549 | 25,852 Direct | -1.02% | Disposed | -61.3% (price as of 2026-08-21) |
| June 8, 2022 | PCRX | S 10b5-1 | 516 | $60.99 | $31,471 | 26,119 Direct | -1.94% | Disposed | -60.7% (price as of 2026-08-21) |
| June 8, 2022 | PCRX | S 10b5-1 | 1,633 | $60.23 | $98,356 | 26,635 Direct | -5.78% | Disposed | -60.2% (price as of 2026-08-21) |
| June 8, 2022 | PCRX | S 10b5-1 | 2,521 | $59.08 | $148,941 | 28,268 Direct | -8.19% | Disposed | -59.4% (price as of 2026-08-21) |
| June 6, 2022 | PCRX | S 10b5-1 | 2,813 | $61.37 | $172,634 | 30,789 Direct | -8.37% | Disposed | -60.9% (price as of 2026-08-21) |
| June 4, 2021 | PCRX | S | 2,117 | $61.04 | $129,222 | 18,681 Direct | -10.18% | Disposed | -60.7% (price as of 2026-08-21) |
| Aug. 3, 2020 | PCRX | S 10b5-1 | 2,500 | $52.68 | $131,700 | 20,796 Direct | -10.73% | Disposed | -54.5% (price as of 2026-08-21) |
| June 29, 2020 | PCRX | S 10b5-1 | 1,778 | $52.03 | $92,509 | 20,250 Direct | -8.07% | Disposed | -53.9% (price as of 2026-08-21) |
| June 29, 2020 | PCRX | S 10b5-1 | 6,859 | $51.77 | $355,090 | 22,028 Direct | -23.74% | Disposed | -53.7% (price as of 2026-08-21) |
| June 29, 2020 | PCRX | S 10b5-1 | 51,464 | $50.01 | $2,573,715 | 28,887 Direct | -64.05% | Disposed | -52.0% (price as of 2026-08-21) |
| June 4, 2020 | PCRX | S | 863 | $46.33 | $39,983 | 10,101 Direct | -7.87% | Disposed | -48.2% (price as of 2026-08-21) |
| June 4, 2019 | PCRX | S | 430 | $42.91 | $18,451 | 5,367 Direct | -7.42% | Disposed | -44.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 14, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (6,000) | $38.35 | June 13, 2028 | 6,000 | Disposed |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (24,800) | $59.39 | June 8, 2032 | 24,800 | Acquired |
| Nov. 22, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (7,500) | $44.10 | June 2, 2027 | 7,500 | Disposed |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (17,500) | $60.96 | June 9, 2031 | 17,500 | Acquired |
| Aug. 3, 2020 | PCRX | Common Stock | Common Stock (2,500) | $44.10 | June 2, 2027 | 2,500 | Disposed |
| June 29, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $44.10 | June 2, 2027 | 30,000 | Disposed |
| June 29, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (7,500) | $43.54 | June 5, 2029 | 7,500 | Disposed |
| June 29, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $38.35 | June 13, 2028 | 15,000 | Disposed |
| June 29, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (3,750) | $37.81 | Jan. 3, 2029 | 3,750 | Disposed |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (35,000) | $47.65 | June 9, 2030 | 35,000 | Acquired |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $43.54 | June 5, 2029 | 30,000 | Acquired |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $38.35 | June 13, 2028 | 30,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.